PeptiDream Inc. (4587.T)

JPY 1815.0

(0.83%)

Long Term Debt Summary of PeptiDream Inc.

  • PeptiDream Inc.'s latest annual long term debt in 2023 was 19.63 Billion JPY , up 6.95% from previous year.
  • PeptiDream Inc.'s latest quarterly long term debt in 2024 Q2 was 18.33 Billion JPY , down -3.41% from previous quarter.
  • PeptiDream Inc. reported annual long term debt of 18.35 Billion JPY in 2022, down 0.0% from previous year.
  • PeptiDream Inc. reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • PeptiDream Inc. reported quarterly long term debt of 18.98 Billion JPY for 2024 Q1, down -3.3% from previous quarter.
  • PeptiDream Inc. reported quarterly long term debt of 17.26 Billion JPY for 2023 Q2, down -3.08% from previous quarter.

Annual Long Term Debt Chart of PeptiDream Inc. (2023 - 2011)

Historical Annual Long Term Debt of PeptiDream Inc. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 19.63 Billion JPY 6.95%
2022 18.35 Billion JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%

Peer Long Term Debt Comparison of PeptiDream Inc.

Name Long Term Debt Long Term Debt Difference
KOHJIN BIO CO LTD 767.03 Million JPY -2459.788%
PRISM BioLab Co.,LTD - JPY -Infinity%
GNI Group Ltd. 2 Billion JPY -881.722%
Linical Co., Ltd. 1.49 Billion JPY -1209.007%
Trans Genic Inc. 1.32 Billion JPY -1379.527%
MEDINET Co., Ltd. 781 Thousand JPY -2513913.7%
Soiken Holdings Inc. - JPY -Infinity%
Cytori Cell Research Institute, Inc. 2.34 Billion JPY -736.548%
AnGes, Inc. 214.94 Million JPY -9034.468%
OncoTherapy Science, Inc. 106.84 Million JPY -18275.883%
Nxera Pharma Co., Ltd. 63.21 Billion JPY 68.94%
Immuno-Biological Laboratories Co., Ltd. 84.56 Million JPY -23119.27%
NanoCarrier Co., Ltd. 1.1 Billion JPY -1670.598%
Carna Biosciences, Inc. 28.4 Million JPY -69030.508%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 875.59 Million JPY -2142.404%
RaQualia Pharma Inc. 39.05 Million JPY -50180.274%
Chiome Bioscience Inc. - JPY -Infinity%
Kidswell Bio Corporation 1.83 Billion JPY -968.274%
Oncolys BioPharma Inc. 161.1 Million JPY -12087.739%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited 397 Million JPY -4845.705%
Healios K.K. 450 Million JPY -4263.21%
BrightPath Biotherapeutics Co., Ltd. - JPY -Infinity%
Kubota Pharmaceutical Holdings Co., Ltd. - JPY -Infinity%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 77.29 Million JPY -25303.277%
FunPep Company Limited - JPY -Infinity%
Kringle Pharma, Inc. - JPY -Infinity%
Stella Pharma Corporation 773.29 Million JPY -2439.073%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. - JPY -Infinity%
Cuorips Inc. - JPY -Infinity%
K Pharma,Inc. - JPY -Infinity%
Takara Bio Inc. 788 Million JPY -2391.681%
ReproCELL Incorporated - JPY -Infinity%
PhoenixBio Co., Ltd. 491.35 Million JPY -3896.012%
StemCell Institute Inc. 6.67 Million JPY -294004.958%
Japan Tissue Engineering Co., Ltd. - JPY -Infinity%
CellSeed Inc. 143.75 Million JPY -13558.746%